Cassava Sciences (SAVA)

Cassava Sciences (SAVA) Stock Price & Analysis


SAVA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$16.55 - $50.77
Previous Close$17.54
Average Volume (3M)943.38K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$168.44M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-8.0
Oct 31, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.19
Shares Outstanding41,969,994
10 Day Avg. Volume840,340
30 Day Avg. Volume943,375
Standard Deviation0.61
Financial Highlights & Ratios
Price to Book (P/B)4.15
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Price Target Upside467.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Cassava Sciences’s price range in the past 12 months?
Cassava Sciences lowest stock price was $16.55 and its highest was $50.77 in the past 12 months.
    What is Cassava Sciences’s market cap?
    Currently, no data Available
    When is Cassava Sciences’s upcoming earnings report date?
    Cassava Sciences’s upcoming earnings report date is Oct 31, 2023 which is in 36 days.
      How were Cassava Sciences’s earnings last quarter?
      Cassava Sciences released its earnings results on Aug 03, 2023. The company reported -$0.63 earnings per share for the quarter, missing the consensus estimate of -$0.59 by -$0.04.
        Is Cassava Sciences overvalued?
        According to Wall Street analysts Cassava Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Cassava Sciences pay dividends?
          Cassava Sciences pays a Notavailable dividend of $5.25 which represents an annual dividend yield of N/A. See more information on Cassava Sciences dividends here
            What is Cassava Sciences’s EPS estimate?
            Cassava Sciences’s EPS estimate is -$0.78.
              How many shares outstanding does Cassava Sciences have?
              Cassava Sciences has 41,969,994 shares outstanding.
                What happened to Cassava Sciences’s price movement after its last earnings report?
                Cassava Sciences reported an EPS of -$0.63 in its last earnings report, missing expectations of -$0.59. Following the earnings report the stock price went down -0.667%.
                  Which hedge fund is a major shareholder of Cassava Sciences?
                  Among the largest hedge funds holding Cassava Sciences’s share is GMT Capital Corp. It holds Cassava Sciences’s shares valued at N/A.


                    Cassava Sciences Stock Smart Score

                    The Cassava Sciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Cassava Sciences

                    Cassava Sciences, Inc. engages in the development of novel drugs. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.


                    Top 5 ETFs holding SAVA

                    Market Value
                    Smart Score
                    Vanguard Total Stock Market ETF
                    Vanguard Health Care ETF
                    Schwab U.S. Broad Market ETF
                    Vanguard Russell 3000 ETF
                    Texas Capital Texas Equity Index ETF
                    Up to five ETFs with an Outperform Smart Score that hold SAVA. The ETFs are listed according to market value of SAVA within the ETF

                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Axsome Therapeutics
                    Bioxcel Therapeutics
                    Annovis Bio

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis